Abstract
The hypothesis that been set forward that use of Renin Angiotensin Aldosterone System (RAAS) inhibitors is associated with COVID-19 severity. We set-up a multicenter Italian collaboration (CORIST Project, ClinicalTrials.gov ID: NCT04318418) to retrospectively investigate the relationship between RAAS inhibitors and COVID-19 in-hospital mortality. We also carried out an updated meta-analysis on the relevant studies.
Lingua originale | English |
---|---|
Numero di pagine | 10 |
Rivista | Vascular Pharmacology |
Volume | 135 |
Stato di pubblicazione | Published - 2020 |
All Science Journal Classification (ASJC) codes
- Physiology
- Molecular Medicine
- Pharmacology